Group One Trading
KRYS icon

Group One Trading’s Krystal Biotech KRYS Stock Holding History

Group One Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$24.7K – 8211
2025
Q4 		$24.7K Sell
100
-3,100
-97% -$652K ﹤0.01% 6198
2025
Q3 		$565K Sell
3,200
-12,600
-80% -$1.89M ﹤0.01% 3584
2025
Q2 		$2.17M Buy
15,800
+13,900
+732% +$2.04M ﹤0.01% 2060
2025
Q1 		$343K Sell
1,900
-13,100
-87% -$2.2M ﹤0.01% 3460
2024
Q4 		$2.35M Buy
15,000
+14,000
+1,400% +$2.48M 0.01% 1777
2024
Q3 		$182K Buy
+1,000
New +$193K ﹤0.01% 3704
2024
Q2 		– Sell
-400
Closed -$71.2K – 7121
2024
Q1 		$71.2K Sell
400
-27,900
-99% -$3.88M ﹤0.01% 4424
2023
Q4 		$3.51M Buy
28,300
+8,700
+44% +$965K 0.01% 1406
2023
Q3 		$2.27M Sell
19,600
-2,000
-9% -$244K 0.01% 1539
2023
Q2 		$2.54M Sell
21,600
-4,000
-16% -$408K 0.01% 1486
2023
Q1 		$2.05M Sell
25,600
-8,200
-24% -$644K 0.01% 1503
2022
Q4 		$2.68M Buy
33,800
+14,500
+75% +$1.08M 0.01% 1591
2022
Q3 		$1.34M Hold
19,300
– – ﹤0.01% 2268
2022
Q2 		$1.27M Buy
19,300
+100
+0.5% +$6.22K ﹤0.01% 2513
2022
Q1 		$1.28M Buy
19,200
+9,100
+90% +$568K ﹤0.01% 2836
2021
Q4 		$707K Buy
+10,100
New +$588K ﹤0.01% 3718
2021
Q3 		– Sell
-600
Closed -$41K – 8483
2021
Q2 		$41K Buy
+600
New +$41.9K ﹤0.01% 6741
2021
Q1 		– Sell
-600
Closed -$36K – 7794
2020
Q4 		$36K Buy
+600
New +$30K ﹤0.01% 5198

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's KRYS Position: Q4 2025 in Review

Group One Trading sold out of Krystal Biotech (KRYS) in Q4 2025, closing a stake of 160 shares — an estimated $33.7K sold.

Group One Trading first reported a position in KRYS in Q2 2020 and held it in 7 quarters. The position peaked at $212K in Q1 2024. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Group One Trading reported no remaining Krystal Biotech position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 160 Krystal Biotech shares in Q4 2025, an estimated $33.7K.
  • Group One Trading first reported a position in Krystal Biotech in Q2 2020 and held it in 7 quarters.
  • Group One Trading's Krystal Biotech position peaked at $212K in Q1 2024.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.